HLA DRB1 polymorphism and risk of HIV/tuberculosis co-infection.

Abstract

5 5% % ɉ ɉɈ ɈɅ Ʌȱ ȱɆ ɆɈ ɈɊ ɊɎ Ɏȱ ȱɁ ɁɆ Ɇ Ɍ ɌȺ Ⱥ Ɋ Ɋɂ ɂɁ Ɂɂ ɂɄ Ʉ ȼ ȼɂ ɂɇ ɇɂ ɂɄ Ʉɇ ɇȿ ȿɇ ɇɇ ɇə ə Ʉ ɄɈ Ɉ ȱ ȱɇ ɇɎ Ɏȿ ȿɄ Ʉɐ ɐȱ ȱȲ Ȳ ȼ ȼȱ ȱɅ Ʌ Ɍ Ɍɍ ɍȻ Ȼȿ ȿɊ ɊɄ Ʉɍ ɍɅ Ʌɖ ɖɈ ɈɁ Ɂ ȾɁ «Ⱦɧɿɩɪɨɩɟɬɪɨɜɫɶɤɚ ɦɟɞɢɱɧɚ ɚɤɚɞɟɦɿɹ ɆɈɁ ɍɤɪɚʀɧɢ» ɤɚɮɟɞɪɚ ɿɧɮɟɤɰɿɣɧɢɯ ɯɜɨɪɨɛ (ɡɚɜ. -ɞ. ɦɟɞ. ɧ., ɩɪɨɮ. Ʌ.Ɋ. ɒɨɫɬɚɤɨɜɢɱ-Ʉɨɪɟɰɶɤɚ) ɜɭɥ. ȼ. ȼɟɪɧɚɞɫɶɤɨɝɨ, 9, Ⱦɧɿɩɪɨ, 49044, ɍɤɪɚʀɧɚ SE «Dnipropetrovsk medical academy Ʉɥɸɱɨɜɿ ɫɥɨɜɚ ɩɨɥɿɦɨɪɮɿɡɦ ɝɟɧɿɜ HLA DRB1, ȼȱɅ-ɿɧɮɿɤɨɜɚɧɿ ɩɚɰɿɽɧɬɢ, ɤɨ-ɿɧɮɟɤɰɿɹ ȼȱɅ/ɬɭɛɟɪɤɭɥɶɨɡ .H\ ZRUGV HLA DRB1 gene polymorphism, HIV-infected patients, co-infection HIV/tuberculosis ɄɅȱɇȱɑɇȺ ɆȿȾɂɐɂɇȺ ɆȿȾɂɑɇȱ ɉȿɊɋɉȿɄɌɂȼɂ / MEDICNI PERSPEKTIVI Ʉɥɸɱɨɜɿ ɫɥɨɜɚ ɝɨɫɬɪɢɣ ɫɟɪɟɞɧɿɣ ɨɬɢɬ, ɝɨɫɬɪɢɣ ɪɢɧɨɫɢɧɭɫɢɬ, ȽɊȼȱ, ɥɿɡɨɰɢɦ, ɞɿɬɢ .H\ ZRUGV acute otitis media, acute rhinosinusitis, URTI, lysozyme, children Ɋɟɮɟɪɚɬ Ɏɚɤɬɨɪɵ ɪɢɫɤɚ ɢ ɨɫɨɛɟɧɧɨɫɬɢ ɬɟɱɟɧɢɹ ɩɨɜɬɨɪɧɵɯ ɛɚɤɬɟɪɢɚɥɶɧɵɯ ɨɫɥɨɠɧɟɧɢɣ ɈɊȼɂ ɭ ɞɟɬɟɣ Ʉɚɪɩɟɧɤɨ Ⱥȼ ɐɟɥɶɸ ɢɫɫɥɟɞɨɜɚɧɢɹ ɫɬɚɥɨ ɨɩɪɟɞɟɥɟɧɢɟ ɮɚɤɬɨɪɨɜ ɪɢɫɤɚ ɪɟɰɢɞɢɜɢɪɭɸɳɢɯ ɛɚɤɬɟɪɢɚɥɶɧɵɯ